Prothena Corp Public (PRTA) Other financing activities (2012 - 2024)

Prothena Corp Public's (PRTA) quarterly Other financing activities came in at -$1000.0 in Q4 2024, down 100.18% year-on-year from $548000.0 in Q1 2024, and down 100.23% quarter-over-quarter from $427000.0 in Q3 2024.

Prothena Corp Public (PRTA) Other financing activities (2012 - 2024) Analysis & Trends

Prothena Corp Public's Other financing activities history runs 12 years deep, the most recent figure standing at -$1000.0 for Q4 2024.

  • On a quarterly basis, Other financing activities fell 100.18% year-over-year to -$1000.0 in Q4 2024; TTM through Sep 2025 was -$1000.0, a 100.04% decrease from a year earlier, with the FY2024 full-year figure at $1.9 million, down 91.14% from the prior year.
  • Other financing activities fell to -$1000.0 in Q4 2024 per PRTA's latest filing, from $427000.0 in the prior quarter.
  • Across five years, Other financing activities topped out at $15.6 million in Q2 2023 and bottomed at -$1000.0 in Q4 2024.
  • The 5-year median for Other financing activities is $1.7 million (2021), against an average of $3.2 million.
  • Across the five-year window, Other financing activities jumped 6368.75% in 2021 and sank 100.18% in 2024, its largest moves.
  • Year by year, Other financing activities stood at $64000.0 in 2020, then soared by 2790.62% to $1.8 million in 2021, then soared by 528.7% to $11.6 million in 2022, then plunged by 95.29% to $548000.0 in 2023, then sank by 100.18% to -$1000.0 in 2024.
  • Per Business Quant, the three latest PRTA Other financing activities figures stand at -$1000.0 (Q4 2024), $427000.0 (Q3 2024), and $591000.0 (Q2 2024).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn
4 NuCana 279.75 Bn 279.75 Bn -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn
7 Belite Bio 62.51 Bn 62.51 Bn -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn -
10 Prothena Corp Public 458.13 Mn 128.67 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2024 -1,000.00
Dec 31, 2024 -1,000.00
Sep 30, 2024 427,000.00
Sep 30, 2024 427,000.00
Jun 30, 2024 591,000.00
Jun 30, 2024 591,000.00
Mar 31, 2024 890,000.00
Mar 31, 2024 890,000.00
Dec 31, 2023 548,000.00
Dec 31, 2023 548,000.00
Sep 30, 2023 2.78 Mn
Sep 30, 2023 2.78 Mn
Jun 30, 2023 15.59 Mn
Jun 30, 2023 15.59 Mn
Mar 31, 2023 2.60 Mn
Mar 31, 2023 2.60 Mn
Dec 31, 2022 11.63 Mn
Dec 31, 2022 11.63 Mn
Sep 30, 2022 4.30 Mn
Sep 30, 2022 4.30 Mn